Biotechnical research, noncommercial
Tolero Pharmaceuticals, Inc
Tolero Pharmaceuticals, a division of Sumitomo Pharma Oncology, is a leading global developer of innovative cancer therapeutics. Their commitment to purposeful science in oncology drives the development of a diverse and targeted pipeline of therapies.
With a focus on novel approaches to cancer treatment, Tolero Pharmaceuticals is dedicated to advancing the promise of precision medicine in the fight against cancer. Learn more about their impactful contributions to the field of oncology. Generated from their website's infomation
